Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Treatment of drug resistant proliferative diseases with telomerase mediated telomere altering compounds

Treatment of drug resistant proliferative diseases with telomerase mediated telomere altering compounds

US Patent 12070472 · Granted Aug 27, 2024

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

GalNAc derivatives2025
Modified nucleoside phosphoramidites2025
Guanine analogs as telomerase substrates and telomere length affectors2025
Sequential treatment of cancers using 6-thio-dG, checkpoint inhibitors and radia2024
Sequential treatment of cancers using 6-thio-dG, checkpoint inhibitors and radia2024
Modified oligonucleotides and methods of use2024
Modified nucleoside phosphoramidites2024
Multivalent delivery of immune modulators by liposomal spherical nucleic acids f2024
Liposomal particles, methods of making same and uses thereof2024
Modified oligonucleotides for use in treatment of tauopathies2022
Guanine analogs as telomerase substrates and telomere length affectors2022
Modified nucleoside phosphoramidites2021